Bellerophon Therapeutics Inc (BLPH)
Stock chart
Earnings
Value bought
Past 90 days
Value sold
Past 90 days
Net insiders buying
Past 90 days
Trades (buy and sell)
Past 90 days
Search
| Notification date | Transaction date | B/S Transaction type | Insider and/or position |
Nb. shares Price Value |
Number of shares | Price | Value | Details |
|---|---|---|---|---|---|---|---|---|
| 2023-10-16 | 2023-10-13 | S Sale |
Puissance Capital Management LP Large shareholder |
1,076,841
-100.0%
0.10USD 111,776 |
1,076,841 -100.0% | 0.10 | USD 111,776 | |
| 2023-06-07 | 2023-06-07 | S Sale |
Puissance Life Science Opportunities Fund VI Large shareholder |
134,421
-11.1%
0.83USD 111,569 |
134,421 -11.1% | 0.83 | USD 111,569 | |
| 2023-05-22 | 2023-05-18 | S Sale |
VP Reg. Affairs & Quality Officer |
9,455
-84.6%
10.00USD 94,550 |
9,455 -84.6% | 10.00 | USD 94,550 | |
| 2023-05-19 | 2023-05-18 | S Sale |
Puissance Life Science Opportunities Fund VI Large shareholder |
560,000
-31.6%
9.46USD 5,297,600 |
560,000 -31.6% | 9.46 | USD 5,297,600 | |
| 2021-03-22 | 2021-03-18 | S Sale |
New Mountain Investments II, LLC Large shareholder |
400,000
-39.6%
5.48USD 2,192,000 |
400,000 -39.6% | 5.48 | USD 2,192,000 | |
| 2020-09-14 | 2020-09-10 | B Purchase |
Chief Medical Officer Officer |
4,000
+inf%
10.18USD 40,708 |
4,000 +inf% | 10.18 | USD 40,708 | |
| 2020-06-09 | 2020-06-08 | B Purchase | Non-Executive Director Large shareholder |
2,600
+4.5%
12.87USD 33,454 |
2,600 +4.5% | 12.87 | USD 33,454 | |
| 2020-06-09 | 2020-06-05 | B Purchase | Non-Executive Director Large shareholder |
4,986
+9.3%
12.72USD 63,442 |
4,986 +9.3% | 12.72 | USD 63,442 | |
| 2019-11-25 | 2019-11-25 | B Purchase | Non-Executive Director Large shareholder |
7,193
+1.2%
0.39USD 2,774 |
7,193 +1.2% | 0.39 | USD 2,774 | |
| 2019-11-25 | 2019-11-22 | B Purchase | Non-Executive Director Large shareholder |
1,050
+0.2%
0.37USD 394 |
1,050 +0.2% | 0.37 | USD 394 | |
| 2019-11-25 | 2019-11-21 | B Purchase | Non-Executive Director Large shareholder |
200
+0.0%
0.37USD 74 |
200 +0.0% | 0.37 | USD 74 | |
| 2019-10-28 | 2019-10-28 | S Sale | Large shareholder |
333,010
-4.9%
0.44USD 146,091 |
333,010 -4.9% | 0.44 | USD 146,091 | |
| 2019-10-28 | 2019-10-28 | S Sale | Large shareholder |
333,010
-4.9%
0.44USD 146,091 |
333,010 -4.9% | 0.44 | USD 146,091 | |
| 2019-10-28 | 2019-10-25 | S Sale | Large shareholder |
56,242
-0.8%
0.45USD 25,511 |
56,242 -0.8% | 0.45 | USD 25,511 | |
| 2019-10-28 | 2019-10-25 | S Sale | Large shareholder |
56,242
-0.8%
0.45USD 25,511 |
56,242 -0.8% | 0.45 | USD 25,511 | |
| 2019-10-28 | 2019-10-24 | S Sale | Large shareholder |
704,595
-9.4%
0.50USD 353,354 |
704,595 -9.4% | 0.50 | USD 353,354 | |
| 2019-10-28 | 2019-10-24 | S Sale | Large shareholder |
704,595
-9.4%
0.50USD 353,354 |
704,595 -9.4% | 0.50 | USD 353,354 | |
| 2019-06-14 | 2019-06-12 | B Purchase | Large shareholder |
50,000
+9.4%
0.64USD 31,905 |
50,000 +9.4% | 0.64 | USD 31,905 | |
| 2019-05-24 | 2019-05-22 | B Purchase | Large shareholder |
27,500
+5.4%
0.60USD 16,533 |
27,500 +5.4% | 0.60 | USD 16,533 | |
| 2019-05-22 | 2019-05-21 | B Purchase |
Chief Executive Officer Executive Director |
5,000
+1.0%
0.60USD 2,975 |
5,000 +1.0% | 0.60 | USD 2,975 | |
| 2019-05-22 | 2019-05-21 | B Purchase |
20,000
+1.1%
0.61USD 12,198 |
20,000 +1.1% | 0.61 | USD 12,198 | ||
| 2019-05-22 | 2019-05-21 | B Purchase | Large shareholder |
43,280
+9.3%
0.61USD 26,371 |
43,280 +9.3% | 0.61 | USD 26,371 | |
| 2019-01-25 | 2019-01-25 | B Purchase | Non-Executive Director Large shareholder |
450,000
+3284.9%
0.70USD 315,000 |
450,000 +3284.9% | 0.70 | USD 315,000 | |
| 2019-01-25 | 2019-01-25 | B Purchase | Non-Executive Director |
714,286
+62.6%
0.70USD 500,000 |
714,286 +62.6% | 0.70 | USD 500,000 | |
| 2019-01-25 | 2019-01-25 | B Purchase | Non-Executive Director |
571,429
+45.8%
0.70USD 400,000 |
571,429 +45.8% | 0.70 | USD 400,000 | |
| 2019-03-14 | 2019-01-23 | B Purchase | Large shareholder |
142,857
+1.9%
0.70USD 100,000 |
142,857 +1.9% | 0.70 | USD 100,000 | |
| 2019-03-14 | 2019-01-23 | B Purchase | Large shareholder |
142,857
+1.9%
0.70USD 100,000 |
142,857 +1.9% | 0.70 | USD 100,000 | |
| 2018-09-17 | 2018-09-17 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
60,000
+0.8%
1.18USD 70,944 |
60,000 +0.8% | 1.18 | USD 70,944 | |
| 2018-09-17 | 2018-09-17 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
60,000
+0.8%
1.18USD 70,944 |
60,000 +0.8% | 1.18 | USD 70,944 | |
| 2018-09-17 | 2018-09-14 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
75,000
+1.0%
1.23USD 92,250 |
75,000 +1.0% | 1.23 | USD 92,250 | |
| 2018-09-17 | 2018-09-14 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
75,000
+1.0%
1.23USD 92,250 |
75,000 +1.0% | 1.23 | USD 92,250 | |
| 2018-09-17 | 2018-09-13 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
75,000
+1.0%
1.19USD 89,160 |
75,000 +1.0% | 1.19 | USD 89,160 | |
| 2018-09-17 | 2018-09-13 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
75,000
+1.0%
1.19USD 89,160 |
75,000 +1.0% | 1.19 | USD 89,160 | |
| 2018-09-12 | 2018-09-12 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
75,000
+1.1%
1.15USD 85,913 |
75,000 +1.1% | 1.15 | USD 85,913 | |
| 2018-09-12 | 2018-09-12 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
75,000
+1.1%
1.15USD 85,913 |
75,000 +1.1% | 1.15 | USD 85,913 | |
| 2018-09-12 | 2018-09-11 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
200,000
+2.9%
1.14USD 228,840 |
200,000 +2.9% | 1.14 | USD 228,840 | |
| 2018-09-12 | 2018-09-11 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
200,000
+2.9%
1.14USD 228,840 |
200,000 +2.9% | 1.14 | USD 228,840 | |
| 2018-09-12 | 2018-09-10 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
200,000
+3.0%
1.22USD 243,640 |
200,000 +3.0% | 1.22 | USD 243,640 | |
| 2018-09-12 | 2018-09-10 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
200,000
+3.0%
1.22USD 243,640 |
200,000 +3.0% | 1.22 | USD 243,640 | |
| 2018-09-07 | 2018-09-07 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
60,000
+0.9%
0.90USD 53,742 |
60,000 +0.9% | 0.90 | USD 53,742 | |
| 2018-09-07 | 2018-09-07 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
60,000
+0.9%
0.90USD 53,742 |
60,000 +0.9% | 0.90 | USD 53,742 | |
| 2018-09-07 | 2018-09-06 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
50,000
+0.8%
0.84USD 42,095 |
50,000 +0.8% | 0.84 | USD 42,095 | |
| 2018-09-07 | 2018-09-06 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
50,000
+0.8%
0.84USD 42,095 |
50,000 +0.8% | 0.84 | USD 42,095 | |
| 2018-09-07 | 2018-09-05 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
50,000
+0.8%
0.85USD 42,325 |
50,000 +0.8% | 0.85 | USD 42,325 | |
| 2018-09-07 | 2018-09-05 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
50,000
+0.8%
0.85USD 42,325 |
50,000 +0.8% | 0.85 | USD 42,325 | |
| 2018-08-16 | 2018-08-16 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
66,393
+1.0%
0.65USD 43,109 |
66,393 +1.0% | 0.65 | USD 43,109 | |
| 2018-08-16 | 2018-08-16 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
66,393
+1.0%
0.65USD 43,109 |
66,393 +1.0% | 0.65 | USD 43,109 | |
| 2018-08-16 | 2018-08-15 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
272,000
+4.4%
0.65USD 175,902 |
272,000 +4.4% | 0.65 | USD 175,902 | |
| 2018-08-16 | 2018-08-15 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
272,000
+4.4%
0.65USD 175,902 |
272,000 +4.4% | 0.65 | USD 175,902 | |
| 2018-08-16 | 2018-08-14 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
190,977
+3.2%
0.65USD 123,868 |
190,977 +3.2% | 0.65 | USD 123,868 | |
| 2018-08-16 | 2018-08-14 | B Purchase |
VENROCK ASSOCIATES IV L P Large shareholder |
190,977
+3.2%
0.65USD 123,868 |
190,977 +3.2% | 0.65 | USD 123,868 | |
| 2017-10-03 | 2017-09-29 | B Purchase |
456,432
0.00USD 0 |
456,432 | 0.00 | USD 0 | ||
| 2017-10-03 | 2017-09-29 | B Purchase |
248,962
0.00USD 0 |
248,962 | 0.00 | USD 0 | ||
| 2017-10-03 | 2017-09-29 | B Purchase | Large shareholder |
10,000
0.00USD 0 |
10,000 | 0.00 | USD 0 | |
| 2016-12-12 | 2016-12-09 | B Purchase | Non-Executive Director Large shareholder |
20,000
+100.7%
0.56USD 11,200 |
20,000 +100.7% | 0.56 | USD 11,200 | |
| 2016-12-01 | 2016-11-29 | B Purchase |
Tenenbaum Fabian Chief Executive Officer Officer |
142,857
0.00USD 0 |
142,857 | 0.00 | USD 0 | |
| 2016-12-01 | 2016-11-29 | B Purchase |
Amin Naseem Non-Executive Director |
714,285
0.00USD 0 |
714,285 | 0.00 | USD 0 | |
| 2016-11-30 | 2016-11-29 | B Purchase |
Peacock Jonathan M Non-Executive Director |
285,715
0.00USD 0 |
285,715 | 0.00 | USD 0 | |
| 2016-05-18 | 2016-05-17 | B Purchase |
President and CEO Executive Director |
5,000
+2.3%
1.37USD 6,842 |
5,000 +2.3% | 1.37 | USD 6,842 | |
| 2015-12-17 | 2015-12-16 | B Purchase |
President and CEO Executive Director |
12,800
+32.9%
2.76USD 35,336 |
12,800 +32.9% | 2.76 | USD 35,336 | |
| 2015-12-17 | 2015-12-15 | B Purchase |
President and CEO Executive Director |
7,500
+23.9%
2.72USD 20,400 |
7,500 +23.9% | 2.72 | USD 20,400 | |
| 2015-08-20 | 2015-08-19 | B Purchase |
President and CEO Executive Director |
5,000
+18.9%
5.48USD 27,377 |
5,000 +18.9% | 5.48 | USD 27,377 | |
| 2015-05-22 | 2015-05-20 | B Purchase |
President and CEO Executive Director |
5,560
+26.6%
8.69USD 48,323 |
5,560 +26.6% | 8.69 | USD 48,323 | |
| 2015-05-22 | 2015-05-20 | B Purchase |
Chief Scientific Officer Officer |
712
+3.9%
8.40USD 5,981 |
712 +3.9% | 8.40 | USD 5,981 | |
| 2015-02-23 | 2015-02-19 | B Purchase | Non-Executive Director Large shareholder |
1,070,166
+28.2%
12.00USD 12,841,992 |
1,070,166 +28.2% | 12.00 | USD 12,841,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase | Non-Executive Director Large shareholder |
1,070,166
+28.2%
12.00USD 12,841,992 |
1,070,166 +28.2% | 12.00 | USD 12,841,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase | Non-Executive Director Large shareholder |
212,666
+28.2%
12.00USD 2,551,992 |
212,666 +28.2% | 12.00 | USD 2,551,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase | Non-Executive Director Large shareholder |
358,916
+28.2%
12.00USD 4,306,992 |
358,916 +28.2% | 12.00 | USD 4,306,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase |
Chief Scientific Officer Officer |
12,000
+187.9%
12.00USD 144,000 |
12,000 +187.9% | 12.00 | USD 144,000 | |
| 2015-02-23 | 2015-02-19 | B Purchase | Non-Executive Director |
25,000
+24.1%
12.00USD 300,000 |
25,000 +24.1% | 12.00 | USD 300,000 | |
| 2015-02-23 | 2015-02-19 | B Purchase |
Chief Business Officer Officer |
1,500
+15.3%
12.00USD 18,000 |
1,500 +15.3% | 12.00 | USD 18,000 | |
| 2015-02-23 | 2015-02-19 | B Purchase |
New Mountain Investments II, LLC Large shareholder |
1,070,166
+28.2%
12.00USD 12,841,992 |
1,070,166 +28.2% | 12.00 | USD 12,841,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase |
ARCH VENTURE FUND VI LP Large shareholder |
212,666
+28.2%
12.00USD 2,551,992 |
212,666 +28.2% | 12.00 | USD 2,551,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase |
Linde North America, Inc. Large shareholder |
358,916
+28.2%
12.00USD 4,306,992 |
358,916 +28.2% | 12.00 | USD 4,306,992 | |
| 2015-02-23 | 2015-02-19 | B Purchase |
Chief Clinical Dev. Officer Officer |
1,500
+18.8%
12.00USD 18,000 |
1,500 +18.8% | 12.00 | USD 18,000 |